2 unique characteristics of retrovirus lifestyle
In lab: Reverse transcription and integration into host chromosome
In clinic: associated with serious human disease
Retrovirus structure/proteins
Structural Proteins:
1) Envelope (gp120, gp 41): derived from host cytoplasmic membrane; determine host range of retroviruses (usually highly specific with respect to host/tissue types)
2) matrix (p17)- between core and envelope
3) capsid: Gag proteins (group associated antigens); p24–may contain protease
4)Viral enzymes: reverse transcriptase, protease (sometimes integrase, ribonuclease H - RNase)
Viral genome: 2 RNA molecules
Lipid bilayer
Life cycle steps of retroviruses
Life cycle steps targeted by anti-retroviral drugs
What cancers are HIV patients getting and why is this important
AIDS-defining:
Non AIDS-defining:
More HIV-infected individuals are dying of HIV-associated cancer. They are more aggressive and progress faster. Lately we have seen decreases in AIDS-related cancers with HAART, but not for Non-AIDS related cancers, perhaps even increase)
Potential Contributing factors to HIV pts developing cancer
What are different in treatment for these cancers
The chemo and antiretroviral drugs can interact and/or have overlapping toxicities.
Chemo agents are often degraded by CYP450 enzymes in liver. Many antiretroviral drugs can inhibit or enhance CYP450 enzymes, altering concentrations of chemotherapy drugs.
What is HTLV
Human T-cell Lymphotropic Virus
-delta-retrovirus that infects human T lymphocytes and causes lymphoproliferative disorders
HTLV epidemiology and transmission
Suggested transmission (not 100% sure)
Human disease caused by HTLV-1
Others needing further study (arthritis, pneumonitis, urinary tract disorders, increased susceptibility to infectious dz)
What is ATL/Types of ATL
4 types:
1) Acute ATL (60%)- median survival 6 mo
2) Lymphomatous ATL (~20%)- similar to acute but few circulating abnormal cells
3) Chronic ATL: median survival 2 years
4) Smoldering ATL (less than 5% of pts; median survival over 5 years)
What factors influence whether HTLV-I infection will induce ATL or HAM
viral strains virus infection route other host immune regulations particular MHC haplotypes viral load
Adult T cell Leukemia/Lymphoma (ATL)
First reported in Japan
ATL Disease Progression
HTLV-I infection
ATL treatment
HTLV-I Associated Myelopathy (HAM)
retroviral genome structure
Major classes of retroviruses
Acute transforming: uncommon in nature; defective replication, requires helper virus
Non-acute transforming: common in nature; competent replication
Transacting: Uncommon in nature; HTLV-1, BLV; competent replication